331 related articles for article (PubMed ID: 16122419)
1. Nutritional regulation of hepatic heme biosynthesis and porphyria through PGC-1alpha.
Handschin C; Lin J; Rhee J; Peyer AK; Chin S; Wu PH; Meyer UA; Spiegelman BM
Cell; 2005 Aug; 122(4):505-15. PubMed ID: 16122419
[TBL] [Abstract][Full Text] [Related]
2. PGC-1alpha: looking behind the sweet treat for porphyria.
Li D
Cell; 2005 Aug; 122(4):487-9. PubMed ID: 16122414
[TBL] [Abstract][Full Text] [Related]
3. Hypothesis: Metabolic targeting of 5-aminolevulinate synthase by tryptophan and inhibitors of heme utilisation by tryptophan 2,3-dioxygenase as potential therapies of acute hepatic porphyrias.
Badawy AA
Med Hypotheses; 2019 Oct; 131():109314. PubMed ID: 31443750
[TBL] [Abstract][Full Text] [Related]
4. ALAS1 gene expression is down-regulated by Akt-mediated phosphorylation and nuclear exclusion of FOXO1 by vanadate in diabetic mice.
Oliveri LM; Davio C; Batlle AM; Gerez EN
Biochem J; 2012 Mar; 442(2):303-10. PubMed ID: 22070747
[TBL] [Abstract][Full Text] [Related]
5. Coactivator PGC-1alpha regulates the fasting inducible xenobiotic-metabolizing enzyme CYP2A5 in mouse primary hepatocytes.
Arpiainen S; Järvenpää SM; Manninen A; Viitala P; Lang MA; Pelkonen O; Hakkola J
Toxicol Appl Pharmacol; 2008 Oct; 232(1):135-41. PubMed ID: 18602936
[TBL] [Abstract][Full Text] [Related]
6. PGC-1alpha negatively regulates hepatic FGF21 expression by modulating the heme/Rev-Erb(alpha) axis.
Estall JL; Ruas JL; Choi CS; Laznik D; Badman M; Maratos-Flier E; Shulman GI; Spiegelman BM
Proc Natl Acad Sci U S A; 2009 Dec; 106(52):22510-5. PubMed ID: 20018698
[TBL] [Abstract][Full Text] [Related]
7. Regulation and tissue-specific expression of δ-aminolevulinic acid synthases in non-syndromic sideroblastic anemias and porphyrias.
Peoc'h K; Nicolas G; Schmitt C; Mirmiran A; Daher R; Lefebvre T; Gouya L; Karim Z; Puy H
Mol Genet Metab; 2019 Nov; 128(3):190-197. PubMed ID: 30737140
[TBL] [Abstract][Full Text] [Related]
8. PGC-1alpha is not mandatory for exercise- and training-induced adaptive gene responses in mouse skeletal muscle.
Leick L; Wojtaszewski JF; Johansen ST; Kiilerich K; Comes G; Hellsten Y; Hidalgo J; Pilegaard H
Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E463-74. PubMed ID: 18073319
[TBL] [Abstract][Full Text] [Related]
9. GCN5 acetyltransferase complex controls glucose metabolism through transcriptional repression of PGC-1alpha.
Lerin C; Rodgers JT; Kalume DE; Kim SH; Pandey A; Puigserver P
Cell Metab; 2006 Jun; 3(6):429-38. PubMed ID: 16753578
[TBL] [Abstract][Full Text] [Related]
10. Defects in energy homeostasis in Leigh syndrome French Canadian variant through PGC-1alpha/LRP130 complex.
Cooper MP; Qu L; Rohas LM; Lin J; Yang W; Erdjument-Bromage H; Tempst P; Spiegelman BM
Genes Dev; 2006 Nov; 20(21):2996-3009. PubMed ID: 17050673
[TBL] [Abstract][Full Text] [Related]
11. Regulation of hepatic fasting response by PPARgamma coactivator-1alpha (PGC-1): requirement for hepatocyte nuclear factor 4alpha in gluconeogenesis.
Rhee J; Inoue Y; Yoon JC; Puigserver P; Fan M; Gonzalez FJ; Spiegelman BM
Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4012-7. PubMed ID: 12651943
[TBL] [Abstract][Full Text] [Related]
12. Enzyme defects in hereditary porphyria.
Civin WH; Epstein E
Ann Clin Lab Sci; 1980; 10(5):395-401. PubMed ID: 6999973
[TBL] [Abstract][Full Text] [Related]
13. Zinc mesoporphyrin represses induced hepatic 5-aminolevulinic acid synthase and reduces heme oxygenase activity in a mouse model of acute hepatic porphyria.
Schuurmans MM; Hoffmann F; Lindberg RL; Meyer UA
Hepatology; 2001 May; 33(5):1217-22. PubMed ID: 11343251
[TBL] [Abstract][Full Text] [Related]
14. Integrated regulation of hepatic metabolism by fibroblast growth factor 21 (FGF21) in vivo.
Fisher FM; Estall JL; Adams AC; Antonellis PJ; Bina HA; Flier JS; Kharitonenkov A; Spiegelman BM; Maratos-Flier E
Endocrinology; 2011 Aug; 152(8):2996-3004. PubMed ID: 21712364
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor gamma coactivator-1alpha, as a transcription amplifier, is not essential for basal and hormone-induced phosphoenolpyruvate carboxykinase gene expression.
Herzog B; Hall RK; Wang XL; Waltner-Law M; Granner DK
Mol Endocrinol; 2004 Apr; 18(4):807-19. PubMed ID: 15044597
[TBL] [Abstract][Full Text] [Related]
16. Intermittent acute porphyria. Clinical and biochemical studies of disordered heme biosynthesis.
Meyer UA
Enzyme; 1973; 16(1):334-42. PubMed ID: 4791052
[No Abstract] [Full Text] [Related]
17. Dietary iron controls circadian hepatic glucose metabolism through heme synthesis.
Simcox JA; Mitchell TC; Gao Y; Just SF; Cooksey R; Cox J; Ajioka R; Jones D; Lee SH; King D; Huang J; McClain DA
Diabetes; 2015 Apr; 64(4):1108-19. PubMed ID: 25315005
[TBL] [Abstract][Full Text] [Related]
18. Clinical, Biochemical and Molecular Characteristics of the Main Types of Porphyria.
Szlendak U; Bykowska K; Lipniacka A
Adv Clin Exp Med; 2016; 25(2):361-8. PubMed ID: 27627571
[TBL] [Abstract][Full Text] [Related]
19. The developmental regulation of peroxisome proliferator-activated receptor-gamma coactivator-1alpha expression in the liver is partially dissociated from the control of gluconeogenesis and lipid catabolism.
Yubero P; Hondares E; Carmona MC; Rossell M; Gonzalez FJ; Iglesias R; Giralt M; Villarroya F
Endocrinology; 2004 Sep; 145(9):4268-77. PubMed ID: 15178647
[TBL] [Abstract][Full Text] [Related]
20. Molecular regulation of 5-aminolevulinate synthase. Diseases related to heme biosynthesis.
May BK; Bhasker CR; Bawden MJ; Cox TC
Mol Biol Med; 1990 Oct; 7(5):405-21. PubMed ID: 2095458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
